Nanoparticles as a source for the treatment of fish diseases
Andrea Corona Altimmunes GLP-1 drug shows positive results for alcohol use disorder On Tuesday, Altimmune announced topline data from their Phase 2 RECLAIM trial showing that pemvidutide, an investigational balanced glucagon/GLP-1 dual receptor agonist, significantly reduced the number of heavy drinking days compared to placebo in patients with moderate to severe alcohol use disorder
Its pretty much the superhero of antioxidants, stepping in to battle those pesky free radicals that can mess with our health
Wang Y, Yen FS, Zhu XG, Timson RC, Weber R, Xing C, et al
The other was my inability to provide any degree of evidence outside of the safe and effective talking point to a friend who chose not to vaccinate her children and defended her stance with actual science
FIRE/YANG This family of IV vitamin therapies has been formulated to provide you with the cofactors and building blocks needed for optimal body function